SEMAGLUTIDE WEEK 1-12 BUNDLE - AN OVERVIEW

The demo realized both of those its Major endpoints, with semaglutide two.four mg demonstrating statistically considerable and top-quality advancements in liver fibrosis without having worsening of steatohepatitis, and resolution of steatohepatitis without any worsening of liver fibrosis in those with MASH when compared to placebo.1Your health care